(XSVN) Bondbloxx Trust - BondBloxx - Overview
Etf: Treasury, Bonds, 7-Year, Duration, Index
Dividends
| Dividend Yield | 4.43% |
| Yield on Cost 5y | 4.49% |
| Yield CAGR 5y | 57.04% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 3.63% |
| Relative Tail Risk | 0.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.51 |
| Alpha | 3.14 |
| Character TTM | |
|---|---|
| Beta | -0.040 |
| Beta Downside | -0.086 |
| Drawdowns 3y | |
|---|---|
| Max DD | 9.45% |
| CAGR/Max DD | 0.37 |
Description: XSVN Bondbloxx Trust - BondBloxx January 18, 2026
BondBloxx Bloomberg Seven-Year Target Duration US Treasury ETF (NYSE ARCA:XSVN) aims to hold at least 80 % of its net assets-plus any investment-purpose borrowings-in U.S. Treasury securities with a weighted-average duration near seven years, using either direct holdings or derivative exposure. The underlying index tracks a subset of the Bloomberg US Treasury Index, and the fund is classified as a non-diversified, long-government ETF.
Key market metrics (as of the most recent quarter) show the fund’s duration risk aligns closely with the 7-year Treasury yield curve, which has been flattening as the Federal Reserve signals a pause in rate hikes; this flattening tends to compress spreads between short- and intermediate-term Treasuries, potentially limiting price appreciation for duration-focused strategies.
Liquidity and cost considerations are also material: XSVN trades with an average daily volume of roughly 30,000 shares and a net expense ratio of 0.20 %, which is competitive relative to peer long-duration Treasury ETFs that often charge 0.25 %–0.30 %.
Investors should monitor the Fed’s balance-sheet runoff and core inflation trends, as both directly influence Treasury yields and therefore the fund’s price volatility and total return.
For a deeper, data-driven analysis of how XSVN fits into a broader fixed-income allocation, you might explore the ValueRay platform’s interactive yield-curve visualizations.
What is the price of XSVN shares?
Over the past week, the price has changed by +0.59%, over one month by +0.19%, over three months by +0.50% and over the past year by +7.22%.
Is XSVN a buy, sell or hold?
What are the forecasts/targets for the XSVN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 52.4 | 9.3% |
XSVN Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 289.5m USD (289.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 289.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 289.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.77% (E(289.5m)/V(289.5m) * Re(5.77%) + (debt-free company))
Discount Rate = 5.77% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)